Mineralys Therapeutics
MLYS
MLYS
87 hedge funds and large institutions have $303M invested in Mineralys Therapeutics in 2023 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 14 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
20% more capital invested
Capital invested by funds: $252M → $303M (+$51M)
13% more funds holding
Funds holding: 77 → 87 (+10)
Holders
87
Holding in Top 10
5
Calls
$4K
Puts
–
Top Buyers
1 | +$8.05M | |
2 | +$4.89M | |
3 | +$4.3M | |
4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.48M |
5 |
American Century Companies
Kansas City,
Missouri
|
+$2.23M |
Top Sellers
1 | -$9.95M | |
2 | -$8.77M | |
3 | -$6.34M | |
4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.54M |
5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$2.02M |